CryoLife Inc Stock News

Cryolife (NYSE:CRY) was upgraded by equities research analysts at ValuEngine from a “hold” rating to a “buy” rating in a research note issued to investors on Friday, ValuEngine reports. Other

Shares of Cryolife Inc (NYSE:CRY) hit a new 52-week low during mid-day trading on Friday . The company traded as low as $16.05 and last traded at $16.71, with a volume of 19729 shares changing hands.

Great West Life Assurance Co. Can bought a new position in shares of Cryolife Inc (NYSE:CRY) during the fourth quarter, according to the company in its most recent filing with the Securities and Excha

ArrowMark Colorado Holdings LLC raised its holdings in Cryolife Inc (NYSE:CRY) by 35.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). T

In 2014 Pat Mackin was appointed CEO of CryoLife, Inc. (NYSE:CRY). This analysis aims first to contrast CEO...

ABIOMED (NASDAQ:ABMD) and Cryolife (NYSE:CRY) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations,

Charles Schwab Investment Management Inc. increased its stake in shares of Cryolife Inc (NYSE:CRY) by 1.8% during the 4th quarter, according to the company in its most recent 13F filing with the Secur

Barclays PLC lifted its stake in Cryolife Inc (NYSE:CRY) by 31.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned

CryoLife Inc:

CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it has received CE Mark for the E-vita Open NEO, a hybrid stent graft system